The movement of nucleophosmin from nucleoli to nucleoplasm in HeLa cells induced by cytotoxic drugs and detected by immunofluorescence is inhibited by concomitant treatment with antimycin A in glucose-free medium. Incubation of HeLa cells with antimycin A (300 nM; 30 min) and glucose-free medium resulted in an approximately 900% decrease in cellular ATP pools. To study the biochemical events involved in nucleophosmin translocation, we used an in vitro system consisting of Triton-permeabilized HeLA cells. Incubation of permeabilized cells with ATP (0.5 mM; 1 h) resulted in the translocation of nucleophosmin from nucleoli to nucleoplasm and cytoplasm.
INTRODUCTION
Nucleoli of rapidly proliferating cancer cells are large, pleomorphic and hyperactive [1] . These highly structured and specialized organelles are the sites of both the synthesis of ribosomal precursor RNA [1] [2] [3] and the assembly and processing of preribosomal ribonucleoprotein particles [4] [5] [6] . Numerous nucleolar proteins, RNA and other elements are involved in the intricate processes that produce ribosomes [7, 8] .
Nucleophosmin (protein B23, N038, numatrin) is a major nucleolar phosphoprotein which is significantly more abundant in tumorous and growing cells than in normal resting cells [9] [10] [11] . This protein is associated with 60 S and 80 S preribosomal particles and is localized in the granular region of the nucleolus where ribosomes are assembled and processed. It forms oligomers which may be essential for its function [12] [13] [14] . Our previous studies have shown that nucleophosmin is translocated from nucleoli to nucleoplasm when cells are treated with certain anticancer drugs, particularly the intercalators [15] [16] [17] [18] [19] [20] [21] . A similar redistribution is also observed in cells during differentiation or in the stationary phase of growth [22] [23] [24] . The mechanism(s) of drug-induced or proliferation-associated redistribution ofnucleophosmin is currently under investigation. We now report that drug-induced nucleophosmin translocation is blocked if ATP content is decreased by antimycin A in glucose-free medium. This inhibition is reversed on addition of glucose, which, even in the presence of antimycin A, causes a rapid rise in cellular ATP content. Our new in vitro assay of nucleophosmin translocation in isolated permeabilized cells instead of whole cultured cells indicates that ATP may promote nucleophosmin translocation from nucleoli to nucleoplasm. The present study reports that ATP is required for this process.
MATERIALS AND 
Immunofluorescence staining
Immunofluorescence staining was performed as previously described [25] . Briefly, HeLa cells grown on slides were fixed in 2 % electron-microscopy-grade formaldehyde in PBS (8.5 mM Na2HPO4, 1.6 mM NaH2PO4, 0.145 M NaCl, pH 7.2) for 20 min at room temperature. The cells were permeabilized with acetone at -20 0C for 3 min. After a wash with PBS, the fixed cells were incubated with the appropriate monoclonal antibody (diluted 1: 30) at 37 'C for 1 h. Then cells were washed (4 x 10 min) in PBS and incubated with fluorescein-conjugated affinity-purified goat anti-mouse IgG (diluted 1:20 with PBS) at 37 chicken serum, 0.9 % NaCl) overnight in the refrigerator. The nitrocellulose sheet was then incubated for 2 h with monoclonal antibody to nucleophosmin (diluted 1:10000 in blocking solution), washed (3 x 15 min) with TBS buffer (20 mM Tris/HCl, pH 7.5, 0.5 M NaCl, 0.1 % Triton X-100) and incubated for 1 h in alkaline phosphatase-conjugated goat anti-mouse antibody (diluted 1:5000 in TBS buffer). The sheet was then washed (3 x 10 min) in TBS buffer before incubation with peroxidase substrates for colour development. E.l.i.s.a. studies HeLa cells (whole cultured cells or isolated permeabilized cells) were suspended in RIPA buffer (100 mM NaCl, 20 mM Na2HPO4, 20 mM NaF, 0.2 mM phenylmethanesulphonyl fluoride, 30 ,ug/ml DNAase, 30 ,tg/ml RNAase, I %0 Triton X-100, 0.1 0 SDS) and the mixture was incubated for 15 min at ice temperature. After centrifugation (10 min, 15000 g) to remove cell debris, the supernatant (cell extract) was serially diluted in PBS containing 0.0001 % BSA and loaded into wells of a microtitre plate (Immulon II). E.l.i.s.a. was performed as previously described by Yung et al. [15] . The monoclonal antibody to nucleophosmin was diluted 1:20000 in PBS before use.
Determination of intracellular ATP concentration
The procedure for measuring ATP content was based on the reactions described by Bucher [26] as modified by Adams [27] . Briefly, the samples (0.5 ml), 0.3 mg ofNADH and 1.0 ml ofwater were added to 1.0 ml of phosphoglyceric acid buffer (Sigma). Glyceraldehyde-3-phosphate dehydrogenase/3-phosphoglyceric phosphokinase enzyme mixture (Sigma) (0.04 ml) was then added to the sample mixture. After 10 min, A340 was recorded using water as a reference. By determining the decrease in A340 on oxidation of NADH, a measure of ATP originally present was obtained.
RESULTS
Antimycin A inhibits nucleophosmin translocation induced by cytotoxic drugs Immunobands at 220 and 37 kDa are observed in both control and actinomycin D-treated cells ( Figure 3 ). There is no detectable degradation of nucleophosmin or change in the ratio of the highmolecular-mass form (previously reported as B23 hexamer [12] ) to the monomeric form after the drug treatment. Taken together, these results indicate that actinomycin D causes redistribution of nucleophosmin from the nucleoli to the nucleoplasm.
It has been reported that ATP content can be decreased by antimycin A and glucose-free medium [28] . In the present report, treatment of HeLa cells with antimycin A (300 nM) in a glucose- In.^9
89 Immunofluorescence staining procedures were performed in Eppendorf tubes. At the final step, cells were mounted in 50% glycerol in PBS (pH 9) on slides and were examined for localization of nucleophosmin using fluorescence microscopy (see the Materials and methods section). +, nucleophosmin translocation (translocation in more than 90% of the cells); -, no nucleophosmin translocation (translocation in less than 10% of the cells) Triplicate 100-cell counts recorded.
In vitro [ATP]
Time nucleophosmin 
Nucleophosmin translocation in vitro
To understand the mechanism of nucleophosmin translocation, it is important to study the process not only in whole cultured cells but also in isolated permeabilized cells. For this reason, we used an in vitro system consisting of Triton-permeabilized HeLa cells. [29] to be capable of nuclear protein transport. Under the Triton-permeabilization conditions of the present study, lamin B is shown to be retained in the nuclei after ATP treatment compared with controls, indicating nuclear integrity ( Figure 5 ). E.l.i.s.a. and Westernblotting experiments show that there is no decrease in nucleophosmin (e.l.i.s.a.; Figure 2b ) or change in the ratio of the highmolecular-mass form to the monomeric form (Western blotting; Figure 3) (Table   Table 3 Induction of in vitro nucleophosmin translocation by ribonucleotide triphosphates . EDTA (0.5 mM; 2 h) was used as a control to eliminate the possibility that ATP or CTP might exaggerate the nucleophosmin translocation effect by chelating Mg2+ (Table 3 ).
In the experiments on whole cells, we show that the effect of cytotoxic drugs on nucleophosmin translocation requires ATP whereas, in permeabilized cells, ATP itself causes transport. To try to understand further the mechanism of nucleophosmin translocation, we examined the effect of cytotoxic drugs in isolated permeabilized cells in the absence or presence of ATP. The results show that incubation with actinomycin D (0.05-1.0 /ag/ml; 1 h) ( 
DISCUSSION
Incubation of HeLa cells with antimycin A in glucose-free medium results in a reduction in cellular ATP pools. The present study shows that antimycin A treatment of cells inhibits the translocation of nucleophosmin from nucleoli to nucleoplasm induced by cytotoxic drugs. This inhibition can be reversed by addition of glucose to the culture. The mechanism relating ATP to nucleophosmin translocation is not at present clear. In this report, we describe the use of a cell-free system (cultured HeLa cells permeabilized with Triton X-100) to study nucleophosmin translocation. Nucleophosmin translocation depends on supplementation of the isolated permeabilized cells with ATP.
Of the other ribonucleotide triphosphates tested (ATPy[S], GTP, CTP, UTP), only CTP also effectively promotes nucleophosmin translocation from nucleoli to nucleoplasm and cytoplasm. Taken together, these results suggest that a mechanism involving ATP and/or CTP plays an important role in nucleophosmin translocation.
Intricate mechanisms that mobilize hundreds of proteins, RNAs and other elements in the nucleolus are orchestrated in a concerted manner to make ribosomes. These mechanisms are dependent on a balanced supply of rRNA and ribosomal proteins and the correct conformation of rRNA [30, 31] . The biosynthesis of ribosomes involves may steps, such as transport of ribosomal proteins to the nucleolus and binding to nascent pre-rRNA, splicing of 45 S RNA, packaging of ribosomal proteins into ribosome subunits, and delivery of the preribosomal ribonucleoprotein through the nucleoplasm to the cytoplasm. Although the function of nucleophosmin has not been defined, there is ample evidence suggesting that it is involved in the assembly of ribosomes [11, 15, 32] . Electron-microscopic studies have indicated that it is concentrated in the granular region of the nucleolus at which the processing of preribosomal particles may take place. Hexameric nucleophosmin has been identified in HeLa cells [12, 14] . Chan [14] has also reported that tumorous or proliferating cells have a higher concentration of hexameric nucleophosmin than non-proliferating cells. As both monomers and hexamers are present in cells [12] , an equilibrium may exist between the two forms, the monomeric form possibly serving as a reservoir for the active hexameric form. A possible function of the hexameric form in preribosomal particles [12] is temporary provision of the correct conformation for rRNA to accommodate ribosomal proteins. Significant sequence similarity between the N-terminal portion of nucleophosmin and Xenopus nucleoplasmin [33] suggests that nucleophosmin has a function analogous to that of nucleoplasmin in chromatin assembly [34, 35] . Nucleophosmin translocation induced by cytotoxic drugs may be the result of destruction or loss of binding sites in the nucleolus or interference with one of the ribosomal processes. The present results showing that there is no decrease in nucleophosmin or change in the ratio of the high-molecular-mass form to the monomeric form during translocation indicates that oligomerization of nucleophosmin may not be the trigger for its translocation. We have previously observed that the localization of nucleophosmin is closely related to the phase of cell growth. Nucleophosmin in exponentially growing cells is found mainly in the nucleolus. Redistribution from nucleoli to nucleoplasm occurs in cells in the stationary phase of growth or during differentiation. These results indicate that nucleophosmin translocation is a normal cellular process. Slowing down growth slows down the many steps in ribosome biosynthesis. Translocation of nucleophosmin from nucleoli to nucleoplasm may thus be observed during slow ribosomal processing. The present results showing that ATP is required for drug-induced nucleophosmin translocation in whole cultured cells as well as its ability to promote translocation in vitro provides an important insight into the mechanism of this process.
On the basis of the equilibration of nucleophosmin between nuclei present in interspecies heterokaryons and the antigenmediated nuclear accumulation of cytoplasmically injected antibodies, Borer et al. [36] have suggested that nucleophosmin shuttles constantly between the nucleus and cytoplasm. Previous studies [12, [14] [15] 32] showed that nucleophosmin is mainly localized in the nucleoli and nucleoplasm and not found in the cytoplasm. The present study reports the presence of nucleophosmin in the cytoplasm. Whether and how nucleophosmin plays a role in nucleocytoplasmic transport of ribosomal components needs further study. The specificity of ATP (and CTP) in promoting nucleophosmin translocation suggests a role for ATP hydrolysis. Nucleotide triphosphatase located in nuclear envelope and intranuclear structures has been implicated in mRNA transport [37] [38] [39] . Why ATP (and CTP) is specifically required and whether ATP hydrolysis or any specific enzyme(s) is involved are currently under investigation.
In conclusion, the permeabilized cell system used here to analyse nucleophosmin translocation should prove particularly useful in future work for identifying important factors involved, for characterizing intermediate steps and for defining other biochemical features of the translocation. This system may also be useful for analysing rRNA that is processed and exported from the nucleoli. Biochemical dissection of nucleophosmin translocation from the nucleoli to the nucleoplasm during the processing of pre-ribosomal particles should be facilitated.
